BRIEF RESEARCH REPORT article
Front. Public Health
Sec. Infectious Diseases: Epidemiology and Prevention
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1487302
Assessing the effects of the COVID-19 pandemic on new ART initiation and viral load access among children and adolescents living with HIV in West Africa: an interrupted time series analysis
Provisionally accepted- 1Département de santé Publique, Université de Lomé, Lomé, Togo
- 2Université de Bordeaux, Institut national de la recherche médicale (Inserm) UMR 1219, Institut de recherche pour le développement (IRD) EMR 271, Bordeaux Population Health Centre, Bordeaux, France
- 3UMR1295 Centre d'Epidémiologie et de Recherche en santé des Populations (CERPOP), Toulouse, France
- 4Département Biomédical et de Santé Publique, Institut de recherche en sciences de la santé (IRSS), Ouagadougou, Burkina Faso
- 5Centre hospitalier universitaire de Cocody, Abidjan, Côte d'Ivoire
- 6Gabriel Toure University Hospital, Bamako, Mali
- 7Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso
- 8Centre National Hospitalier Universitaire, Cotonou, Benin
- 9Korle Bu Teaching Hospital, Accra, Ghana
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Before the COVID-19 pandemic, the pediatric continuum of HIV care lagged behind that of adults. The present study aimed to describe the effects of the COVID-19 pandemic on access to HIV care among children and adolescents (0-19 years) living with HIV (CALHIV) in five West African countries. Methods: Within this observational multicenter study, we conducted an interrupted time series analysis by including all antiretroviral therapy (ART)-naive CALHIV newly enrolled between 2018 and 2021. Two monthly documented outcomes were analyzed, namely, the number of ART initiators and the number of viral load (VL) tests performed. We fitted Poisson segmented regression models to estimate immediate changes at pandemic onset and per-pandemic trends through incidence rate ratios (IRRs) with 95% confidence intervals (CIs). Results: Immediately after the start of the pandemic, the average number of ART initiations decreased by 83.8% in Burkina Faso (IRR: 0.162; [95%CI: 0.043-0.609]) and 70.9% in Ghana (IRR: 0.291 [0.171-0.494]). Similarly, the number of VL tests performed decreased by 51% in Burkina Faso (IRR: 0.409 [0.253-0.662]). There were no significant trends in the number of ART initiations during the pandemic, except in Ghana (IRR: 1.146 [1.073-1.224]). The number of VL tests performed monthly in clinics in Côte d'Ivoire and Ghana decreased during the pandemic. Conclusion: ART initiation and VL testing activities were maintained in the majority of West African pediatric clinics, despite the COVID-19 pandemic and subsequent crisis. HIV care continuum monitoring in CALHIV should be maintained during the postpandemic period to identify and mitigate potential lasting effects.
Keywords: HIV, COVID-19 pandemic, ART initiation, VL testing, West Africa
Received: 27 Aug 2024; Accepted: 23 May 2025.
Copyright: © 2025 KONU, Malateste, Desmonde, Dahourou, Amorissani-Folquet, Sally, Yonaba, Tossa-Bagnan, Dame, Ekouevi and Leroy. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Rodion KONU, Département de santé Publique, Université de Lomé, Lomé, Togo
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.